JP2005501847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501847A5 JP2005501847A5 JP2003520739A JP2003520739A JP2005501847A5 JP 2005501847 A5 JP2005501847 A5 JP 2005501847A5 JP 2003520739 A JP2003520739 A JP 2003520739A JP 2003520739 A JP2003520739 A JP 2003520739A JP 2005501847 A5 JP2005501847 A5 JP 2005501847A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkylamino
- alkoxy
- hydroxy
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 24
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000003282 alkyl amino group Chemical group 0.000 claims 10
- -1 benzo [1,3] dioxol-5-yl Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 6
- 239000012458 free base Substances 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- YCAACZFPADQMAR-UHFFFAOYSA-N 6-[4-(2-methoxyethoxymethyl)phenyl]-5-methyl-3-phenyl-[1,2]oxazolo[4,5-c]pyridin-4-one Chemical compound C1=CC(COCCOC)=CC=C1C(N(C1=O)C)=CC2=C1C(C=1C=CC=CC=1)=NO2 YCAACZFPADQMAR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119911.6A GB0119911D0 (en) | 2001-08-15 | 2001-08-15 | Organic Compounds |
| PCT/EP2002/009134 WO2003015780A2 (en) | 2001-08-15 | 2002-08-14 | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501847A JP2005501847A (ja) | 2005-01-20 |
| JP2005501847A5 true JP2005501847A5 (https=) | 2005-10-06 |
Family
ID=9920454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520739A Withdrawn JP2005501847A (ja) | 2001-08-15 | 2002-08-14 | イソキサゾロピリジノン類 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7087756B2 (https=) |
| EP (1) | EP1418912B1 (https=) |
| JP (1) | JP2005501847A (https=) |
| KR (1) | KR20040029429A (https=) |
| CN (1) | CN100384418C (https=) |
| AR (1) | AR036351A1 (https=) |
| AT (1) | ATE355059T1 (https=) |
| BR (1) | BR0211903A (https=) |
| CA (1) | CA2454762A1 (https=) |
| CO (1) | CO5560566A2 (https=) |
| DE (1) | DE60218484T2 (https=) |
| EC (1) | ECSP044971A (https=) |
| ES (1) | ES2282467T3 (https=) |
| GB (1) | GB0119911D0 (https=) |
| HU (1) | HUP0401325A3 (https=) |
| IL (1) | IL160018A0 (https=) |
| MX (1) | MXPA04001419A (https=) |
| NO (1) | NO20040659L (https=) |
| PE (1) | PE20030356A1 (https=) |
| PL (1) | PL366848A1 (https=) |
| PT (1) | PT1418912E (https=) |
| RU (1) | RU2004107847A (https=) |
| WO (1) | WO2003015780A2 (https=) |
| ZA (1) | ZA200400525B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002102807A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
| WO2005113519A1 (en) * | 2004-05-14 | 2005-12-01 | Irm Llc | Compounds and compositions as ppar modulators |
| WO2007098047A2 (en) * | 2006-02-16 | 2007-08-30 | The Mclean Hospital Corporation | Methods and compositions for the treatment of parkinson's disease |
| AU2007275301A1 (en) | 2006-07-20 | 2008-01-24 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1 |
| FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
| FR2933609B1 (fr) * | 2008-07-10 | 2010-08-27 | Fournier Lab Sa | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson. |
| CN102361640B (zh) * | 2009-01-13 | 2016-10-19 | 范安德尔研究所 | 异噁唑吡啶酮在制备用于缓解或减轻温血哺乳动物关节炎和哮喘的症状的药物中的用途 |
| FR2950053B1 (fr) | 2009-09-11 | 2014-08-01 | Fournier Lab Sa | Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
| FR2955110A1 (fr) | 2010-01-08 | 2011-07-15 | Fournier Lab Sa | Nouveaux derives de type pyrrolopyridine benzoique |
| DE102011085038A1 (de) | 2011-10-21 | 2013-04-25 | Tesa Se | Verfahren zur Kapselung einer elektronischen Anordnung |
| JP2016531852A (ja) | 2013-09-25 | 2016-10-13 | ヴァン アンデル リサーチ インスティテュート | 非常に強力なグルココルチコイド |
| KR20170033630A (ko) | 2015-09-17 | 2017-03-27 | (주)다올 | 도로용 경계블럭 |
| EP3525870B1 (en) | 2016-10-14 | 2023-05-10 | Van Andel Research Institute | Highly potent glucocorticoids |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7602542L (sv) | 1975-03-14 | 1976-09-15 | Sandoz Ag | 3-(alfa-iminobensyl)-4-hydroxi-2(lh)-pyridoner |
| US4064251A (en) * | 1976-06-25 | 1977-12-20 | Sandoz, Inc. | Substituted hydroxy pyridones |
| US4049813A (en) * | 1976-07-15 | 1977-09-20 | Sandoz, Inc. | Substituted isoxazolo pyridinones |
| US4238616A (en) | 1977-01-19 | 1980-12-09 | Sandoz, Inc. | 3-(Substituted)phenyl-5-(β-hydroxyphenethyl)-N-(alkyl)-isoxazole-4-carboxamides |
| DE2801190A1 (de) * | 1977-01-19 | 1978-07-20 | Sandoz Ag | 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat |
| US4113727A (en) * | 1977-04-26 | 1978-09-12 | Sandoz, Inc. | Process for the preparation of substituted isoxazolo[4,5-c]pyridin-4-(5H)-ones |
| WO2002102807A1 (en) * | 2001-06-14 | 2002-12-27 | Banyu Pharmaceutical Co., Ltd. | Novel isoxazolopyridone derivatives and use thereof |
-
2001
- 2001-08-15 GB GBGB0119911.6A patent/GB0119911D0/en not_active Ceased
-
2002
- 2002-08-13 AR ARP020103046A patent/AR036351A1/es unknown
- 2002-08-14 DE DE60218484T patent/DE60218484T2/de not_active Expired - Lifetime
- 2002-08-14 RU RU2004107847/15A patent/RU2004107847A/ru not_active Application Discontinuation
- 2002-08-14 PT PT02772157T patent/PT1418912E/pt unknown
- 2002-08-14 EP EP02772157A patent/EP1418912B1/en not_active Expired - Lifetime
- 2002-08-14 JP JP2003520739A patent/JP2005501847A/ja not_active Withdrawn
- 2002-08-14 ES ES02772157T patent/ES2282467T3/es not_active Expired - Lifetime
- 2002-08-14 CN CNB028159268A patent/CN100384418C/zh not_active Expired - Fee Related
- 2002-08-14 HU HU0401325A patent/HUP0401325A3/hu unknown
- 2002-08-14 AT AT02772157T patent/ATE355059T1/de not_active IP Right Cessation
- 2002-08-14 MX MXPA04001419A patent/MXPA04001419A/es unknown
- 2002-08-14 KR KR10-2004-7002124A patent/KR20040029429A/ko not_active Ceased
- 2002-08-14 PE PE2002000734A patent/PE20030356A1/es not_active Application Discontinuation
- 2002-08-14 CA CA002454762A patent/CA2454762A1/en not_active Abandoned
- 2002-08-14 BR BR0211903-0A patent/BR0211903A/pt not_active IP Right Cessation
- 2002-08-14 PL PL02366848A patent/PL366848A1/xx not_active Application Discontinuation
- 2002-08-14 IL IL16001802A patent/IL160018A0/xx unknown
- 2002-08-14 WO PCT/EP2002/009134 patent/WO2003015780A2/en not_active Ceased
- 2002-08-14 US US10/486,569 patent/US7087756B2/en not_active Expired - Fee Related
-
2004
- 2004-01-23 ZA ZA200400525A patent/ZA200400525B/en unknown
- 2004-02-03 EC EC2004004971A patent/ECSP044971A/es unknown
- 2004-02-13 NO NO20040659A patent/NO20040659L/no not_active Application Discontinuation
- 2004-03-12 CO CO04023011A patent/CO5560566A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005501847A5 (https=) | ||
| CN1155600C (zh) | 2,3-二芳基吡唑并[1,5-b]哒嗪衍生物,其制备方法和用作环氧酶2抑制剂 | |
| CN104662021B (zh) | 新的双环吡啶酮类 | |
| JP2002513793A5 (https=) | ||
| EP2308828A3 (en) | CaSR antagonist | |
| JP2005511698A5 (https=) | ||
| JP2005053931A5 (https=) | ||
| JP2008505171A5 (https=) | ||
| CA2944308A1 (en) | Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators | |
| JP2003503449A5 (https=) | ||
| JP2023533855A (ja) | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 | |
| IL165763A0 (en) | Process for preparing 5-(1,3-oxazol-2-yl)benzoic acid derivatives | |
| RU2004107847A (ru) | Изоксазолпиридиноны и их применение в лечении болезни паркинсона | |
| JP2005517677A5 (https=) | ||
| JP2004525178A5 (https=) | ||
| CN1039416C (zh) | 新的吡啶并[3,2－b][1,5]苯并硫代吖庚因的制备方法 | |
| JP2007515467A5 (https=) | ||
| JP2005519989A5 (https=) | ||
| JP2005516898A5 (https=) | ||
| JP2004538278A5 (https=) | ||
| JP2003503487A5 (https=) | ||
| CN1154646C (zh) | 作为α2－拮抗剂的苯并异噁唑和苯基酮 | |
| CN1279609A (zh) | 选择性5－HT1A拮抗剂和选择性h5－HT1B拮抗剂或部分激动剂的组合物 | |
| JP2008512367A5 (https=) | ||
| EP2226321A3 (en) | Process for producing thiazolidinediones and intermediates thereof |